Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 54 publications
Enzalutamide Monotherapy for the Treatment of Prostate Cancer with High-Risk Biochemical Recurrence: EMBARK Secondary End Points: Erratum.
Journal: The Journal of urology
Published: July 09, 2026
Clinically relevant endpoints and quality-of-life outcomes with darolutamide in patients with metastatic hormone-sensitive prostate cancer: Analyses of the phase III ARASENS trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 23, 2026
Aglatimagene besadenovec (CAN-2409) with radiotherapy for patients with localised prostate cancer: a phase 3, multicentre, randomised, double-blind, placebo-controlled trial.
Journal: The Lancet. Oncology
Published: January 06, 2026
Enzalutamide Monotherapy for the Treatment of Prostate Cancer With High-Risk Biochemical Recurrence: EMBARK Secondary End Points.
Journal: The Journal of urology
Published: December 05, 2025
Improved Survival with Enzalutamide in Biochemically Recurrent Prostate Cancer.
Journal: The New England journal of medicine
Published: October 22, 2025
Safety and Tolerability of Relugolix in Combination with Abiraterone or Apalutamide for Treatment of Patients with Advanced Prostate Cancer: Data from a 52-Week Clinical Trial.
Journal: Targeted oncology
Published: March 17, 2025
Plain language summary: does enzalutamide treatment with or without leuprolide improve outcomes and affect quality of life in patients with high-risk biochemical recurrence?
Journal: Future oncology (London, England)
Published: December 12, 2024
Testosterone recovery post discontinuation of androgen deprivation for the treatment of advanced prostate cancer.
Journal: Future oncology (London, England)
Published: November 18, 2024
Initial clinical experience with [177Lu]Lu-PNT2002 radioligand therapy in metastatic castration-resistant prostate cancer: dosimetry, safety, and efficacy from the lead-in cohort of the SPLASH trial.
Journal: Frontiers in oncology
Published: August 20, 2024
Best Patient Care Practices for Administering PSMA-Targeted Radiopharmaceutical Therapy.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: July 05, 2024
Enzalutamide and Quality of Life in Biochemically Recurrent Prostate Cancer.
Journal: NEJM evidence
Published: February 06, 2024
Last Updated: 09/26/2026